DELMAR PHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 5th, 2016 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of _____________, 2016, by and between DelMar Pharmaceuticals, Inc. a Nevada corporation (the “Company”), and the investors set forth on the signature pages affixed hereto (each, an “Investor” and, collectively, the “Investors”).
DELMAR PHARMACEUTICALS, INC. ROYALTY AGREEMENTRoyalty Agreement • May 5th, 2016 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This ROYALTY AGREEMENT (this “Royalty Agreement”) is made and entered into as of _________, 2016, by and between DelMar Pharmaceuticals, Inc. a Nevada corporation (the “Company” or “DelMar”), and the investors set forth on the signature pages affixed hereto (each, an “Investor” and, collectively, the “Investors”).
DELMAR PHARMACEUTICALS, INC. COMMON STOCK WARRANTCommon Stock Warrant • May 5th, 2016 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations
DelMar Pharmaceuticals, Inc., a Nevada corporation (the "Company"), hereby certifies that, as partial compensation for its services as advisor to the Company,________________________________________ or its registered assigns (the "Holder"), is entitled to purchase from the Company up to a total of ________ shares of common stock, par value $0.001 per share (the “Common Stock”) (each, a “Warrant” and collectively, the “Warrants,” and each such share of Common Stock, a "Warrant Share" and all such shares of Common Stock, the "Warrant Shares"), at any time and from time to time commencing 180 days from the Original Issue Date, and through and including ________ , 2021, the fifth anniversary of the Original Issue Date (the "Expiration Date"), and subject to the following terms and conditions:
